Optometry Today: New glaucoma treatment trialled in Manchester

9 August 2018
Source: Optometry Today

The patients at Manchester Royal Eye Hospital are the first in the UK to trial the eyeWatch surgical implant.

The eyeWatch is a new fully adjustable surgical implant that drains excess eye fluid that is caused by glaucoma. It is the first ever glaucoma device that enables post-operative flow adjustment in the clinic.

The eyeWatch, which is manufactured by Rheon Medical, includes an implant that is inserted through the skin at the front of the eye. It is then connected to a drainage tube that filters excess fluid to the back of the eye where it is reabsorbed. There is a built-in magnetically controlled flow mechanism that allows the surgeon to open and close the device using a magnetic pen.

The device was trialled by three patients in Manchester.

Full story on the Optometry Today website

Related Posts